[Advances in Experimental Medicine and Biology] Lung Cancer and Personalized Medicine Volume 893 || Target Therapy in Lung Cancer
- 作者Ahmad, Aamir; Gadgeel, Shirish
- 文件大小224.89KB
- 发表时间2016
- DOI10.1007/978-3-319-24223-1_6
- 页码127-136
Biologics to Treat Substance Use Disorders || Introduction: Biologics to Treat Substance Use Disorders: Vaccines, Monoclonal Antibodies, and EnzymesMontoya, Ivan D. · 2016
Biologics to Treat Substance Use Disorders || Monoclonal AntibodiesMontoya, Ivan D. · 2016
Biologics to Treat Substance Use Disorders || Adenovirus-Based Vaccines for the Treatment of Substance Use DisordersMontoya, Ivan D. · 2016
Biologics to Treat Substance Use Disorders || Nanoparticle-Based Nicotine VaccineMontoya, Ivan D. · 2016
Biologics to Treat Substance Use Disorders || Anti-cocaine Monoclonal AntibodiesMontoya, Ivan D. · 2016
Biologics to Treat Substance Use Disorders || Skin Vaccination Against Nicotine AddictionMontoya, Ivan D. · 2016
Biologics to treat substance use disorders: current status and new directions.Pravetoni, Marco · Human Vaccines & Immunotherapeutics · 2016
Biologics to Treat Substance Use Disorders || Monoclonal AntibodiesMontoya, Ivan D. · 2016
Parenting knowledge among substance abusing women in treatmentMartha L. Velez; Lauren M. Jansson; Ivan D. Montoya; Wendy Schweitzer; Archie Golden; Dace Svikis · 2004
Improvement in naltrexone treatment compliance with contingency managementKenzie L. Preston; Kenneth Silverman; Annie Umbricht; Anna DeJesus; Ivan D. Montoya; Charles R. Schuster · 1999
A model for pharmacological research—treatment of cocaine dependenceIvan D. Montoya; Judith M. Hess; Kenzie L. Preston; David A. Gorelick · 1995
Buprenorphine for human immunovirus-positive opiate-dependent patientsIvan D. Montoya; Annie Umbricht; Kenzie L. Preston · 1995
Biologics to Treat Substance Use Disorders || Nanoparticle-Based Nicotine VaccineMontoya, Ivan D. · 2016
Biologics to Treat Substance Use Disorders || Anti-cocaine Monoclonal AntibodiesMontoya, Ivan D. · 2016